Booster vaccination: The role of reduced antigen content vaccines as a preschool booster

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Gabutti, Giovanni ^a   Trucchi, Cecilia ^b   Conversano, Michele ^c   Zivelonghi, Giambattista ^d   Zoppi, Giorgio ^a  

^a LHU 4 Chiavarese Liguria Region   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Hospital of Taranto   (Italy)

^d Department of Public Health/Hygiene   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; POLIOMYELITIS VACCINE;

BOOSTER VACCINATION; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNOGENICITY; MASS IMMUNIZATION; MEDICAL DOCUMENTATION; PRESCHOOL CHILD; REVIEW; VACCINATION; WORLD HEALTH ORGANIZATION; IMMUNIZATION; IMMUNOLOGY; META ANALYSIS;

CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HUMANS; IMMUNIZATION, SECONDARY; VACCINATION;

EID: 84896312237     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/541319     Document Type: Review

References (51)

1. WHO, Vaccine Introduction Guidelines. Adding a Vaccine to a National Immunization Programme: Decision and Implementation 2005 WHO. http://www.who.int/vaccines-documents
2. CDC, General recommendations on immunization. Recommendations of the advisory committee on immunization practices. Morbidity and Mortality Weekly Report 2011 60 2 1 64 2-s2.0-79952459799
3. Conferenza permanente per i rapporti tra lo Stato, Regioni e le Province Autonome di Trento e Bolzano. Intesa 22 febbraio 2012. Intesa ai sensi dell'art 8, comma 6, della legge 5 giugno 2003, n.131, tra il Governo, le Regioni e le Province Autonome di Trento e Bolzano, sul documento recante, Piano Nazionale Prevenzione Vaccinale 2012-2014. (PNPV, 2012-2014). GU n. 60 del 12-03-2012-Suppl. ordinario n. 47
4. Marino M. G., Franco E., Immunization in the 3rd, 5th and 11th month of age: an Italian intuition. Igiene e Sanità Pubblica 2008 64 3 391 401 2-s2.0-59449093990
5. ECDC, Scientific Panel on Childhood Immunisation Schedule: Diphtheria-Tetanus-Pertussis (DTP) Vaccination 2009 Stockholm, Sweden ECDC Guidance. http://www.ecdc.europa.eu/en/publications/Publications/0911-GUI- Scientific-Panel-on-Childhood-Immunisation-DTP.pdf
6. Gabutti G., The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis. Journal of Preventive Medicine and Hygiene 2008 49 1 47 54 2-s2.0-48949095559
7. Mark A., Bjorkstén B., Granstrom M., Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine 1995 13 7 669 673 2-s2.0-0029063452 10.1016/0264-410X(94) 00017-H
8. Relyveld E. H., Bizzini B., Gupta R. K., Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids. Vaccine 1998 16 9-10 1016 1023 2-s2.0-0032077994 10.1016/S0264-410X(97)00288-0 (Pubitemid 28276017)
9. Edelman K., Malmstrom K., He Q., Savolainen J., Terho E. O., Mertsola J., Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization. European Journal of Pediatrics 1999 158 12 989 994 2-s2.0-0032732138
10. Liese J. G., Stojanov S., Zink T. H., Froeschle J., Klepaldo R., Kronwitter A., Harzer E., Jow S., Belohradsky B. H., Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Pediatric Infectious Disease Journal 2001 20 10 981 988 2-s2.0-0034785553 10.1097/00006454-200110000-00012 (Pubitemid 32952676)
11. Rennels M. B., Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Seminars in Pediatric Infectious Diseases 2003 14 3 196 198 2-s2.0-0043022155 10.1016/S1045-1870(03) 00033-5 (Pubitemid 36994971)
12. Scheifele D. W., Halperin S. A., Ochnio J. J., Ferguson A. C., Skowronski D. M., A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial. Pediatric Infectious Disease Journal 2005 24 12 1059 1066 2-s2.0-29444447521 10.1097/01.inf.0000190028.96152.46 (Pubitemid 43011060)
13. Robbins J. B., Schneerson R., Trollfors B., Sato H., Sato Y., Rappuoli R., Keith J. M., The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins. Journal of Infectious Diseases 2005 191 1 81 88 2-s2.0-11144305922 10.1086/426454 (Pubitemid 40041404)
14. Rowe J., Yerkovich S. T., Richmond P., Suriyaarachchi D., Fisher E., Feddema L., Loh R., Sly P. D., Holt P. G., Th2-associated local reactions to the acellular diphtheria-tetanus- pertussis vaccine in 4- to 6-year-old children. Infection and Immunity 2005 73 12 8130 8135 2-s2.0-28444461797 10.1128/IAI.73.12.8130-8135.2005 (Pubitemid 41740300)
15. Scheifele D. W., Ochnio J. J., Halperin S. A., Cellular immunity as a potential cause of local reactions to booster vaccination with diphtheria and tetanus toxoids and acellular pertussis antigens. Pediatric Infectious Disease Journal 2009 28 11 985 989 2-s2.0-70350525283 10.1097/INF.0b013e3181a9cc2a
16. Gabutti G., Conversano M., Ferrera G., Matera R., Parlato A., Zivelonghi G., Azzari C., Update on the Role of DTpa-IPV Vaccine as a Booster in the Pre-School Age 2010 Stockholm, Sweden Eurovaccine
17. Conferenza permanente per i rapporti tra lo Stato, Regioni e le Province Autonome di Trento e Bolzano, Determinazione 3 marzo 2005. Accordo ai sensi dell'art 4 del decreto legislativo 28 agosto 1997, n.281, tra il Ministro della salute e i Presidenti delle regioni e delle province autonome, concernente il Nuovo Piano Nazionale Vaccini 2005-2007. GU n.86 del 14-04-2005-Suppl. ordinario n.63
18. Ciofi Degli Atti M. L., Salmaso S., Cotter B., Gallo G., Alfarone G., Pinto A., Bella A., Von Hunolstein C., Reactogenicity and immunogenicity of adult versus paediatric diphtheria and tetanus booster dose at 6 years of age. Vaccine 2001 20 1-2 74 79 2-s2.0-0035850997 10.1016/S0264-410X(01)00316-4 (Pubitemid 32905316)
19. Forsyth K. D., Wirsing von Konig C.-H., Tan T., Caro J., Plotkin S., Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007 25 14 2634 2642 2-s2.0-33947160992 10.1016/j.vaccine.2006.12.017 (Pubitemid 46400927)
20. Huang L.-M., Chang L.-Y., Tang H., Bock H. L., Lu C.-Y., Huang F.-Y., Lin T.-Y., Lee C.-Y., Immunogenicity and reactogenicity of a reduced-antigen- content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents. Journal of Adolescent Health 2005 37 6 517.e1 517.e5 2-s2.0-27944432479 10.1016/j.jadohealth.2005.08.009 (Pubitemid 41681774)
21. Jacquet J. M., Bégué P., Grimprel E., Reinert P., Sandbu S., Silfverdal S. A., Faldella G., Nolan T., Lambert S., Richmond P., Marshall H., Roberton D., Schuerman L., Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review. Vaccine 2006 24 13 2440 2448 2-s2.0-33344464742 10.1016/j.vaccine.2005.12.009 (Pubitemid 43290428)
22. Zepp F., Cheuvart B., Wolter J., Anti-diphtheria antibodies should persist until adolescence after a reduced-antigen diphtheria, tetanus and acellular pertussis vaccine (dTpa) in pre-school-aged children. Proceedings of the 21st Annual Meeting of the European Society of Pediatric Infectious Diseases (ESPID '03) 2003 Taormina, Italy Giardini Naxos
23. Sänger R., Behre U., Krause K.-H., Loch H.-P., Soemantri P., Herrmann D., Schmitz-Hauss E., Wolter J., Hoet B., Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccine. European Journal of Pediatrics 2007 166 12 1229 1236 2-s2.0-35648942210 10.1007/s00431-006-0403-x (Pubitemid 350029473)
24. Bose A., Dubey A. P., Gandhi D., Pandit A., Raghu M. B., Raghupathy P., Rao M. I. S., Verghese V. P., Datta S. K., Bock H. L., Safety and reactogenicity of a low-dose diphtheria-tetanus-acellular pertussis vaccine (Boostrix) in pre-school Indian children. Indian Pediatrics 2007 44 6 421 424 2-s2.0-34347239609 (Pubitemid 46997983)
25. Kohl K. S., Walop W., Gidudu J., Ball L., Halperin S., Hammer S. J., Heath P., Varricchio F., Rothstein E., Schuind A., Hennig R., Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine 2007 25 31 5858 5874 2-s2.0-34447252154 10.1016/j.vaccine.2007.04.056 (Pubitemid 47043210)
26. Black S., Friedland L. R., Ensor K., Weston W. M., Howe B., Klein N. P., Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age. Pediatric Infectious Disease Journal 2008 27 4 341 346 2-s2.0-41649090009 10.1097/INF.0b013e3181616180 (Pubitemid 351483070)
27. Meyer C. U., Habermehl P., Knuf M., Hoet B., Wolter J., Zepp F., Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation. Human Vaccines 2008 4 3 203 209 2-s2.0-48249091958
28. Lin T.-Y., Wang Y.-H., Huang Y.-C., Chiu C.-H., Pen Y. L., Tang H., Hoet B., Bock H. L., Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine. Human Vaccines 2008 4 1 50 53 2-s2.0-44649095664 (Pubitemid 351785261)
29. Zhu F., Zhang S., Hou Q., Zhang Y., Xu Y., Ma X., Lu X., Pan H., Chen D., Ramakrishnan G., Zhao R., Tang H., Van Der Meeren O., Bock H. L., Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix). Human Vaccines 2010 6 3 263 269 2-s2.0-77953627539 10.4161/hv.6.3.10503
30. Quinn P., Gold M., Royle J., Buttery J., Richmond P., McIntyre P., Wood N., Lee S.-S., Marshall H., Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old. Vaccine 2011 29 25 4230 4237 2-s2.0-79956199195 10.1016/j.vaccine.2011.03.088
31. Pancharoen C., Chotpitayasunondh T., Chuenkitmongkol S., Ortiz E., Long-term immunogenicity assessment of a DTaP-IPV//PRP-T vaccine given at 2, 4, 6 and 18-19 months of age, and immunogenicity and safety of a DTaP-IPV vaccine given as a booster dose at 4 to 6 years of age in Thai children. The Southeast Asian Journal of Tropical Medicine and Public Health 2012 43 3 687 698
32. Alguacil Ramos A. M., Portero Alonso A., Pastor Villalba E., Martin Ivorra R., Lluch Rodrigo J. A., Analysis of the AEFI associated with the DTaP and dTap vaccine. Valencian community. Proceedings of the 30th Annual meeting of the European Society for Paediatric Infectious Disease (ESPID '12) 2012 Thessaloniki, Greece
33. Ferrera G., Cuccia M., Mereu G., Icardi G., Bona G., Esposito S., Marchetti F., Messier M., Kuriyakose S., Hardt K., Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: a randomized, controlled trial in children primed according to a 2+1 schedule in infancy. Human Vaccines and Immunotherapeutics 2012 8 3 345 352 2-s2.0-84860379057 10.4161/hv.8.3.18650
34. Cheuvart B., Burgess M., Zepp F., Mertsola J., Wolter J., Schuerman L., Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model. Vaccine 2004 23 3 336 342 2-s2.0-7744238483 10.1016/j.vaccine.2004.06.012 (Pubitemid 39463052)
35. Kosuwon P., Warachit B., Hutagalung Y., Borkird T., Kosalaraksa P., Bock H. L., Poovorawan Y., Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered as a booster to 4-6 year-old children primed with four doses of whole-cell pertussis vaccine. Vaccine 2003 21 27-30 4194 4200 2-s2.0-0347448155 10.1016/S0264- 410X(03)00496-1 (Pubitemid 37130264)
36. McIntyre P. B., Burgess M. A., Egan A., Schuerman L., Hoet B., Booster vaccination of adults with reduced-antigen-content diphtheria, tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination. Vaccine 2009 27 7 1062 1066 2-s2.0-58549098277 10.1016/j.vaccine.2008.11.102
37. Mertsola J., He Q., van der Meeren O., The decennial administration of reduced antigen dTpavaccine (Boostrix) in young adults. Incidence of solicited local symptoms classified by prevaccination antibody concentrations. Proceedings of the 27th Annual Meeting of European Society for Paediatric Infectious Diseases (ESPID '09) 2009 Brussels, Belgium
38. Mertsola J., Zepp F., van der Meeren O., The immunogenicity and asfety of repeated administration of dTap booster in adolescents and young adults. Proceedings of the 27th Annual Meeting of European Society for Paediatric Infectious Diseases (ESPID '09) 2009 Brussels, Belgium
39. Mertsola J., Booy R., He Q., The immunogenicity of repeated administration of reduced antigen content dTpa booster vaccine in adults. Proceedings of the 6th World Congress of the Society for Pediatric Infectious Diseases (ESPID '09) 2009 Buenos Aires, Argentina
40. Mertsola J., van der Meeren O., He Q., Linko-Parvinen A., Ramakrishnan G., Mannermaa L., Soila M., Pulkkinen M., Jacquet J.-M., Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults. Clinical Infectious Diseases 2010 51 6 656 662 2-s2.0-77955955721 10.1086/655825
41. Knuf M., Vetter V., Celzo F., Ramakrishnan G., van der Meeren O., Jacquet J. M., Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix IPV). Human Vaccines 2010 6 7 554 561 2-s2.0-77957002518
42. Scott L. J., Spotlight on Tdap5 vaccine (Covaxis) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (Aged ≥4 Years), adolescents, and adults. Pediatric Drugs 2011 13 2 133 135 2-s2.0-79952133898 10.2165/11206990-000000000-00000
43. Bozen South Tyrol P. A., La vaccinazione protegge. Infectious diseases prevention, 2009, http://www.provincia.bz.it/sanita/download/Italienisch-Impfen. pdf
44. Bollettino Ufficiale della Regione Puglia n. 124 del 12/08/2009. Deliberazione della Giunta Regionale 21/07/2009, n. 1286 Commissione tecnico-scientifica regionale Vaccini-D.G.R. n. 245/08,. Modifica Calendario Vaccinale Regione Puglia 2008. Adozione Calendario Vaccinale Regione Puglia 2009, http://www.regione.puglia.it/web/files/sanita/calendario-vaccinale-2010. pdf
45. Salmaso S., Mastrantonio P., Tozzi A. E., Stefanelli P., Anemona A., Ciofi degli Atti M. L., Giammanco A., Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 2001 108 5, article e81 2-s2.0-0035512245
46. Diez-Domingo J., Delgado J. D., Ballester A., Baldó J. M., Planelles M. V., Garcés M., Graullera M., Úbeda M. I., Sánchez F., Sánchez M. M., Azor E., Cabrera A., López F., Álvarez M., San-Martín M., González A., Boisnard F., Thomas S., Immunogenicity and reactogenicity of a combined adsorbed tetanus toxoid, low dose diphtheria toxoid, five component acellular pertussis and inactivated polio vaccine in six-year-old children. Pediatric Infectious Disease Journal 2005 24 3 219 224 2-s2.0-20144373296 10.1097/01.inf.0000154339.72774.b0 (Pubitemid 40365855)
47. Nilsson L., Faldella G., Jacquet J.-M., Storsaeter J., Silfverdal S.-A., Ekholm L., A fourth dose of DTPa-IPV vaccine given to 4-6 year old children in Italy and Sweden following primary vaccination at 3, 5 and 11-12 months of age. Scandinavian Journal of Infectious Diseases 2005 37 3 221 229 2-s2.0-14944362390 10.1080/00365540410020884 (Pubitemid 40372848)
48. Dhillon S., DTPa-HBV-IPVHib vaccine (infanrix hexaTM): a review of its use as primary and booster vaccination. Drugs 2010 70 8 1021 1058 2-s2.0-77952667403 10.2165/11204830-000000000-00000
49. Italian Society of Hygiene, Preventive Medicine, Public Health (SItI), the Italian Federation of Paediatricians (FIMP), the Italian Society of Pediatrics (SIP), the Italian Society of General Practitioners (SIMMG), Calendario vaccinale per la vita. http://www.societaitalianaigiene.org/cms/ images/docs/calendariovaccinale/2012/cvplv.pdf
50. CDC, Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report 2011 60 1 13 15 2-s2.0-79952154352
51. Skibinski D. A. G., Baudner B. C., Singh M., O'Hagan D. T., Combination vaccines. Journal of Global Infectious Diseases 2011 3 1 63 72 2-s2.0-79952979544 10.4103/0974-777X.77298